Logo image
Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor
Journal article   Open access   Peer reviewed

Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor

Yaqing Shu, Youming Long, Shisi Wang, Wanming Hu, Jian Zhou, Huiming Xu, Chen Chen, Yangmei Ou, Zhengqi Lu, Alexander Y Lau, …
Annals of clinical and translational neurology, Vol.6(2), pp.392-396
2019
PMCID: PMC6389737
PMID: 30847372
pdf
Published1,018.32 kBDownloadView
CC BY-NC-ND V4.0 Open Access

Abstract

Autoantibodies - adverse effects Demyelinating Diseases - chemically induced Demyelinating Diseases - diagnosis Demyelinating Diseases - pathology Encephalomyelitis - drug therapy Encephalomyelitis - pathology Humans Immunologic Factors - metabolism Male Middle Aged Multiple Sclerosis - drug therapy Multiple Sclerosis - pathology Myelin-Associated Glycoprotein - metabolism Myelin-Oligodendrocyte Glycoprotein - metabolism Nervous System Malformations - drug therapy Nervous System Malformations - pathology Oligodendroglia - drug effects Oligodendroglia - metabolism
Our objective was to examine the brain biopsies by histopathology and investigate the prognosis of patients with myelin oligodendrocyte glycoprotein antibody-associated demyelinating pseudotumor. The clinical, MRI, and histological features of two patients with myelin oligodendrocyte glycoprotein antibody-associated demyelinating pseudotumor were reviewed. Both patients were treated with steroid plus rituximab and followed up. The brain biopsies of both cases revealed T cells, macrophages, and complement-mediated demyelination, which was in accord with multiple sclerosis-like pathology. Moreover, both cases showed favorable response to steroid plus rituximab therapy. Our cases add a new variant to the myelin oligodendrocyte glycoprotein-encephalomyelitis spectrum, which favorably responds to immunotherapy.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

21 File views/ downloads
15 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.203 Neuromuscular Disorders
1.203.147 Multiple Sclerosis
Web Of Science research areas
Clinical Neurology
Neurosciences
ESI research areas
Neuroscience & Behavior
Logo image